Tibet Aim Pharm Inc (002826) — Capital Reinvestment Ratio
Tibet Aim Pharm Inc (002826) has a Capital Reinvestment Ratio of 0.03x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥87.55 Million) in capital expenditures (CN¥3.02 Million). Check Tibet Aim Pharm Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tibet Aim Pharm Inc Capital Reinvestment Ratio (2013–2025)
This chart tracks Tibet Aim Pharm Inc's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Tibet Aim Pharm Inc.
Annual Capital Reinvestment Ratio for Tibet Aim Pharm Inc (2013–2025)
Year-by-year Capital Reinvestment Ratio for Tibet Aim Pharm Inc from 2013 to 2025. See free cash flow generation of Tibet Aim Pharm Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | CN¥123.72 Million | CN¥8.50 Million | ▼ -37.4% |
| 2024 | 0.11x | CN¥111.57 Million | CN¥12.24 Million | ▲ +475.7% |
| 2023 | 0.02x | CN¥166.88 Million | CN¥3.18 Million | ▼ -59.2% |
| 2022 | 0.05x | CN¥68.45 Million | CN¥3.20 Million | ▼ -79.7% |
| 2021 | 0.23x | CN¥109.52 Million | CN¥25.20 Million | ▼ -39.1% |
| 2020 | 0.38x | CN¥101.74 Million | CN¥38.43 Million | ▼ -86.9% |
| 2019 | 2.88x | CN¥59.20 Million | CN¥170.45 Million | ▼ -43.4% |
| 2018 | 5.09x | CN¥13.31 Million | CN¥67.72 Million | ▲ +426.8% |
| 2017 | 0.97x | CN¥77.29 Million | CN¥74.62 Million | ▲ +198.0% |
| 2016 | 0.32x | CN¥57.18 Million | CN¥18.52 Million | ▼ -98.4% |
| 2014 | 20.66x | CN¥2.18 Million | CN¥45.12 Million | ▲ +3671.3% |
| 2013 | 0.55x | CN¥52.24 Million | CN¥28.62 Million | — |